Cloopen Prices Friction, Not Cash

Cloopen Group Holding Limited (RAASY.US) closed at $2.20 on May 18, 2026, while the signed going-private merger price is $2.9641 per ADS. The buyer group already controls 57.25% of the voting power, support agreements are signed, and a $42 million term facility is committed. The tape is not really debating price. It is charging a steep discount for OTC illiquidity, Cayman Islands process friction, and calendar time. [1][2][3]

Opportunity Ranking

Rank	Idea	Discovery Lane	Why It May Be Best Now	Evidence Freshness	Catalyst Window	Asymmetry	Main Reason to Reject
1	Cloopen prices friction, not cash	Broader Asia / China ADR / OTC / going-private	Definitive merger at $2.9641 per ADS, buyer group controls 57.25% of voting power, support agreements are signed, and financing is committed, yet the ADS closed at $2.20	SEC 6-K and PR Newswire dated May 12, 2026; live quote checked May 19, 2026 [1][2][3]	Schedule 13E-3 filing and shareholder vote path into Q4 2026	+34.7% gross to the merger price from the current close	Selected
2	Alfresa still trades below its own buyback print	Japan / large-cap / buyback / healthcare distribution	The company bought stock in ToSTNeT-3 at ¥2,300 and the shares still closed at ¥2,254.5 on May 18	Buyback disclosures dated May 15 and May 18, 2026; live quote checked May 19, 2026 [4][5]	Execution and cancellation path through the summer	Clean capital-return floor	Rejected. Valid, but the upside is narrower and the source stack is thinner than Cloopen’s.
3	Two Harbors still trades the auction premium	U.S. / merger arb / competing bids	The stock closed at $12.43, above CCM’s $12.00 cash deal and just below UWMC’s $12.50 cash election, while ISS and Glass Lewis urged holders to vote against CCM	Merger and proxy materials dated May 8 to May 13, 2026; live quote checked May 19, 2026 [6][7][8]	Special meeting on May 19, 2026	Real process tension	Rejected. The lane is still driven by bidder game theory, and the desk already covered the same disagreement on May 4, 2026.
4	Essensys compulsory acquisition still leaves a small gap	Europe / UK / AIM / compulsory acquisition	Offer is unconditional at 17p and acceptances already reached 97.01%, yet the last quoted share price sat at 16.35p	RNS announcements dated May 8 to May 14, 2026; quote surface checked May 19, 2026 [9][10]	Squeeze-out and cancellation path after the offer	The cash gap is real	Rejected. The remaining position is too illiquid and procedurally messy for the best daily note.

Selected opportunity: RAASY.US

Why this one now: It has the best current mix of asymmetry, evidence freshness, and still-real tradeability. The spread is large, the merger is definitive, the buyer already controls the vote, and the financing is named and committed. The risk is not whether the buyer exists. The risk is whether minority holders are being paid enough to wait through an OTC and Cayman process.

What should surprise the reader: A founder-led buyer group can already control the vote, sign the merger, line up financing, and still watch the ADR trade 25.8% below the cash consideration. That is not normal spread behavior. It is a friction tax.

Geographic Search Audit

U.S. candidate screened: Two Harbors (TWO.US). Rejected because the process remains driven by live bid sequencing and the desk already published that core disagreement earlier in May.
Japan candidate screened: Alfresa Holdings (2784.T). Rejected because the buyback thesis is sound but the upside is smaller and the closing mechanism is less discrete.
Broader Asia candidate screened: Cloopen (RAASY.US / China ADR). Selected.
Europe / UK candidate screened: Essensys (ESYS.UK). Rejected because the post-offer residual holder position is too illiquid and procedurally awkward.

The Setup

Cloopen is a China-based cloud communications company incorporated in the Cayman Islands. Its U.S. traded ADSs quote on the OTC market under RAASY, and each ADS represents six Class A ordinary shares. [1][2]

On May 12, 2026, Cloopen announced a definitive Agreement and Plan of Merger with a buyer group led by founder and CEO Changxun Sun. The group also includes Trustbridge funds, a Dmall subsidiary, Novo Investment HK, Image Frame Investment (HK), Parantoux Vintage PE, and Flawless Success. [1][2]

At closing, each public ADS will be cancelled for $2.9641 in cash, and each underlying ordinary share will be cancelled for $0.4940 in cash, excluding excluded shares and any dissenting shares. [1]

The merger is not a preliminary letter. It is a signed deal. The Cloopen board approved it after a unanimous recommendation from a special committee of independent and disinterested directors. [1]

The financing is also not hand-wavy. Parent entered into a debt commitment letter under which China Minsheng Banking Corp., Ltd. Shanghai Pilot Free Trade Zone Branch agreed to provide up to $42 million of term financing for the merger, subject to conditions. [1]

The buyer group already beneficially owns about 28.42% of the issued and outstanding shares, which translates into about 57.25% of aggregate voting power. Certain buyer-group members also signed support agreements committing their shares to vote in favor of the merger. [1]

The company said the transaction is expected to close in Q4 2026 and will require approval by at least two-thirds of the votes cast by shareholders present and voting at the shareholder meeting under Cayman Islands law and the company’s governing documents. [1]

The Mispricing

At $2.20, the ADS closes $0.7641 below the merger consideration. That is a 25.8% discount to signed cash. [3]

This discount does not seem to come from one obvious deal-breaking variable.

It is not a no-financing deal. Financing is committed. [1]
It is not a no-control deal. The buyer group already holds 57.25% of the voting power and support agreements are signed. [1]
It is not a non-binding proposal. The merger agreement is definitive and already filed with the SEC on Form 6-K. [1]

The market is therefore charging for friction:

OTC illiquidity. The tape is thin, spreads can be wide, and many institutions cannot or will not do the work for a sub-$3 China ADR on OTC Pink. [3]
Cayman vote mechanics. The approval threshold is two-thirds of votes cast, not of all outstanding shares, and ADS holders still have to navigate depositary process rather than vote common directly. [1]
Calendar risk. Closing is expected in Q4 2026, not next week, so the market applies a waiting discount. [1]
Founder-control distrust. The company is China-based, founder-led, and being taken private by insiders. Minority holders know that these files can drag, and they demand a large haircut for that reason.

Those frictions are real. The question is whether they are worth 25.8% of the merger price when the buyer already controls the vote and the financing is already named.

Price

Metric	Value	Source
RAASY close, May 18, 2026	$2.20	Stooq [3]
RAASY open, May 18, 2026	$2.31	Stooq [3]
RAASY high, May 18, 2026	$2.31	Stooq [3]
RAASY low, May 18, 2026	$2.20	Stooq [3]
RAASY volume, May 18, 2026	14,364 ADSs	Stooq [3]
Merger price per ADS	$2.9641	SEC 6-K / Exhibit 99.1 [1]
Merger price per ordinary share	$0.4940	SEC 6-K / Exhibit 99.1 [1]
Gap to merger price	$0.7641	Calculated from the two lines above
Discount to merger price	25.8%	Calculated from the two lines above
Buyer-group voting power	57.25%	SEC 6-K / Exhibit 99.1 [1]
Buyer-group share ownership	28.42% of issued and outstanding shares	SEC 6-K / Exhibit 99.1 [1]
Debt commitment	Up to $42 million	SEC 6-K / Exhibit 99.1 [1]
Expected closing	Q4 2026	SEC 6-K / Exhibit 99.1 [1]
Required shareholder approval	Two-thirds of votes cast	SEC 6-K / Exhibit 99.1 [1]

Positioning

This is not a classic crowded U.S. merger-arb file.

Fact: The buyer group is already the dominant voting bloc. [1]

Fact: The instrument is an OTC Pink ADS, not a listed U.S. common stock. [3]

Inference: A meaningful part of the current register may simply be unable or unwilling to warehouse the name through a Cayman proxy cycle, depositary mechanics, and an uncertain Q4 close date. That kind of holder often sells first and leaves the event spread to specialists. The problem is that many specialists also do not want a thin OTC China ADR.

Missing data: I did not verify live short interest, stock-loan availability, or the exact remaining free-float composition in this run. Those would help time the compression, but they are not load-bearing for the high-level thesis.

Catalyst

There are three tangible catalysts.

Catalyst 1: the Schedule 13E-3 / proxy package. The company said it will prepare and mail a Schedule 13E-3 transaction statement that will include the proxy statement. That filing should make the process more legible to U.S. ADS holders. [1]

Catalyst 2: the shareholder vote. The buyer group already controls 57.25% of the voting power and signed support agreements. Because the approval threshold is two-thirds of votes cast rather than all outstanding shares, the buyer’s hurdle is lower than many surface readers assume. [1]

Catalyst 3: time itself. A big part of the discount is just that closing is not tomorrow. Every step that moves the file closer to a dated vote or a dated closing should chip away at the friction discount if the papers remain unchanged.

Payoff Map

The cleanest expression is long RAASY.US ADS common stock. This is a signed-cash-discount setup. Common stock captures that directly.

I did not verify a tradable listed options chain in this run, and on an OTC ADR there often is no liquid listed options market worth using. That makes this a common-stock-only idea.

Price Target and Probability Map

Scenario	Probability	Target / Level	Return / Payoff	Time Horizon	Conditions Required	Evidence Quality
Top Case	55%	$2.9641	+34.7%	3 to 6 months	Merger closes on the signed terms and ADS holders receive the full cash consideration	High
Base Case	25%	$2.60	+18.2%	1 to 3 months	The Schedule 13E-3 and vote path reduce the friction discount before closing	Medium
Bottom Case	20%	$1.40	-36.4%	1 to 6 months	The deal breaks, is materially delayed, or is repriced after business or process deterioration	Medium
Invalidation / Stop Condition	n/a	Deal termination or a cut in merger economics below the current tape	Thesis broken	Immediate once visible	The edge depends on the paper still being worth $2.9641	High

Probability-weighted expected value: about $2.57 per ADS, or about +16.8% versus the current $2.20 close.

Current market price / level: RAASY.US $2.20 close on May 18, 2026. [3]

Timestamp: Quote checked May 19, 2026, 15:43 ICT using Stooq’s daily record for the prior U.S. session. [3]

Primary instrument: RAASY ADS common stock.

Alternative expressions considered: None were publish-ready. I did not verify a liquid options chain, and an OTC ADR is not the place to invent one.

Confidence: Medium

What Could Go Wrong

The strongest counterargument is straightforward: this is not a mispricing. It is a rational discount for illiquidity, time, and offshore process risk.

That argument has real force.

The stock trades OTC and only changed hands in 14,364 ADSs on May 18. [3]
The buyer group controls the vote, but the company still needs to run a Cayman Islands shareholder meeting and a U.S. ADS-holder communication process. [1]
Founder-led take-private files can drag, and minority holders know it.
China-linked transaction risk is not imaginary. Even when financing is committed, timing and paperwork can still create dead air.

There is also a more specific structural risk. The approval test is two-thirds of votes cast, not a simple majority, so the buyer group does not already have the threshold alone if turnout is high and the rest of the register votes against. The support agreements matter, but they do not eliminate all procedural uncertainty. [1]

What Would Prove This Wrong

The thesis fails if:

The merger agreement is terminated.
The merger economics are cut below the current tape.
The financing commitment is withdrawn or materially impaired.
A filing shows a legal or process problem that makes a Q4 close unrealistic.
The ADS falls below $1.40 on new process or fundamental information, not just on thin-volume tape noise.

A plain delay does not automatically kill the idea. A change in the papers does.

Bottom Line

Cloopen is not trading at $2.20 because the market thinks the signed buyer price is fictional. It is trading at $2.20 because the instrument is awkward, the process is offshore, and the holder base is being asked to wait.

That is a real discount. It does not look like a 25.8% discount.

The buyer controls the vote. The financing is committed. The merger agreement is signed. The paper says $2.9641. The tape still says $2.20. That gap is large enough to matter.

Research Quality Scorecard

The full scorecard is kept in the companion meta file.